Insiders XORTX Therapeutics Inc.

Equities

XRTX

CA98420Q3061

Market Closed - Toronto S.E. Other stock markets 20:59:14 10/05/2024 BST			5-day change	1st Jan Change
3.46 ^CAD	-3.08%		-5.21%	+19.31%

04-22	XORTX Therapeutics Announces Publication of Key Research in ADPKD in Peer-reviewed Journal	MT
04-22	XORTX Announces Publication of Key Research in ADPKD	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

XORTX Therapeutics Inc. Appoints Abigail Jenkins to the Board of Directors	04-08	CI
XORTX Therapeutics Inc. Appoints Ronald Perrone as Clinical Advisory Board	03-27	CI
XORTX Therapeutics Inc. Announces Board Changes	01-02	CI
XORTX Therapeutics Brief: Appointing James Fairbairn as Chief Financial Officer to replace Amar Keshri who left the Co's employ effective July 31, 2023; Fairbairn was appointed Interim CFO on June 28, 2023	04/08/23	MT
XORTX Therapeutics Names James Fairbairn Interim Chief Financial Officer; Shares Gain	29/06/23	MT
XORTX Therapeutics Names James Fairbairn Interim Chief Financial Officer	29/06/23	MT
XORTX Therapeutics Inc. Appoints James Fairbairn as Interim Chief Financial Officer	29/06/23	CI
XORTX Therapeutics Inc. Announces Departure of Jacqueline Le Saux	29/06/23	CI
XORTX Therapeutics Appoints Former Pfizer Executive Stacy Evans as Chief Business Officer	16/11/22	MT
XORTX Therapeutics Appoints Stacy Evans as Chief Business Officer	16/11/22	CI
Update on MT Newswires Canada Stocks To Watch: PyroGenesis Canada and HPQ Silicon Inc; Reunion Neuroscience; XORTX Therapeutics; Vox Royalty Corp and NioCorp	11/10/22	MT
MT Newswires Canada Stocks To Watch: PyroGenesis Canada; Reunion Neuroscience; XORTX Therapeutics; Vox Royalty Corp and NioCorp	11/10/22	MT
XORTX Therapeutics Names Board Chairman	06/06/22	MT
XORTX Therapeutics Inc. Appoints Anthony Giovinazzo to the Board of Directors and as Chair of the Board	06/06/22	CI
XORTX Therapeutics Brief: Appoints Dr. David MacDonald as Chief Technology Officer; Says He Has An Over 30-year "Record of Achievement" in Drug Development and Leadership in Pharma and Biotech	20/01/22	MT
XORTX Therapeutics Inc. Appoints Dr. David Macdonald as Chief Technology Officer	20/01/22	CI
XORTX Therapeutics Down 4.5% in US Pre-Market as Appoints Altasciences as CRO for Clinical Study	02/12/21	MT
XORTX Therapeutics Inc. Management Changes	23/11/21	CI
XORTX Names Dr. Charles Edelstein as New Clinical Advisory Board Member	31/08/21	CI
Dr. Stephen Haworth Joins XORTX Therapeutics Inc. as Chief Medical Officer	30/06/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders XORTX Therapeutics Inc.

Equities

XRTX

CA98420Q3061

Insiders

Filters